Gara Jalqabaatti › Saree Oljoo › New Jersey › Newark
Qorannoo klinikaalii Saree Oljoo Newark, NJ keessatti
Qorannoo 18 Saree Oljoo f Newark fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Summit Health, Florham Park · Miili 12 fagaatti
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Morristown Medical Center, Morristown · Miili 17 fagaatti
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Medical Oncology Hematology Associates, Newark
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Summit Medical Group, Florham Park · Miili 12 fagaatti
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Newark
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Livingston · Miili 9 fagaatti
- Summit Medical Group PA, Florham Park · Miili 12 fagaatti
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Namoota walitti qabaa jiraSadarkaa 3
- Summit Medical Group, Florham Park · Miili 12 fagaatti
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Summit Medical Group, Florham Park · Miili 12 fagaatti
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Namoota walitti qabaa jiraQorannoo ilaalaa
- Summit Medical Group, Florham Park · Miili 12 fagaatti
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Namoota walitti qabaa jiraSadarkaa 3
- Newark Beth Israel Medical Center, Newark
- Cooperman Barnabas Medical Center, Livingston · Miili 9 fagaatti
- Morristown Medical Center, Morristown · Miili 17 fagaatti
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Namoota walitti qabaa jiraSadarkaa 2
- GSK Investigational Site, Morristown · Miili 17 fagaatti
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Namoota walitti qabaa jiraSadarkaa 3
- Morristown Medical Center, Morristown · Miili 17 fagaatti
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Namoota walitti qabaa jira
- Rutgers State University of New Jersey Medical School, Newark
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Namoota walitti qabaa jiraQorannoo ilaalaa
- Morristown Medical Center, Morristown · Miili 17 fagaatti
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Namoota walitti qabaa jira
- Summit Health, Florham Park · Miili 12 fagaatti
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
Namoota walitti qabaa jiraSadarkaa 1
- RWJBarnabas Health Clara Maas Medical Center, Belleville · Miili 4 fagaatti
- Cooperman Barnabas Medical Center, Livingston · Miili 9 fagaatti
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Namoota walitti qabaa jiraSadarkaa 2
- RWJBarnabas Health - Newark Beth Israel Medical Center, Newark
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Namoota walitti qabaa jiraSadarkaa 4
- Cancer Center Initiative, Newark
- University Hospital, Newark
- RWJBarnabas Health Newark Beth Israel Medical Center, Newark
- fi 2 dabalataa
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Namoota walitti qabaa jiraSadarkaa 3
- Morristown Medical Center, Morristown · Miili 17 fagaatti
Qorannoo Saree Oljoo magaalota biroo keessatti
- New York City, NYQorannoo 136
- Houston, TXQorannoo 126
- Boston, MAQorannoo 112
- Nashville, TNQorannoo 81
- Los Angeles, CAQorannoo 73
- Edison, NJQorannoo 68
- St. Louis, MOQorannoo 64
- Queens, NYQorannoo 64
- Durham, NCQorannoo 64
- Chicago, ILQorannoo 59
- Philadelphia, PAQorannoo 56
- Dallas, TXQorannoo 55
Qorannoo biroo Newark keessatti
- Miidhaa Sirna CaddiiQorannoo 13
- Kansara Qara'a Non-Small CellQorannoo 13
- Leukemia Myeloidii HamaaQorannoo 12
- Cufama OnneeQorannoo 10
- Kansara MetastatikiiQorannoo 10
- Dhibee Onneessaa fi DhiigaQorannoo 9
- Kansarii PancreasQorannoo 9
- MelanomaQorannoo 8
- Saree (Gosoota Hunda)Qorannoo 7
- Dhibee QaraQorannoo 7
- Dhukkuba KrooniiQorannoo 7
- Stenosis valvii aortaQorannoo 6
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.